ACG: fecal transplant safe in primary sclerosing cholangitis

ACG: fecal transplant safe in primary sclerosing cholangitis

(HealthDay)—Fecal microbiota transplantation (FMT) from a rationally selected donor seems safe and effective for patients with primary sclerosing cholangitis (PSC), according to a study presented at the World Congress of Gastroenterology, being held in partnership with the American College of Gastroenterology's annual scientific meeting and postgraduate course Oct. 13 to 18 in Orlando, Florida.

Jessica R. Allegretti, M.D., M.P.H., from Brigham & Women's Hospital in Boston, and colleagues enrolled 10 PSC with concurrent inflammatory bowel disease to examine their safety, liver enzyme, and microbiome profiles after FMT. To date, six of the patients have undergone a single FMT by colonoscopy from a healthy donor, selected rationally.

The researchers found that by week 26, three of six patients had a ≥50 percent decrease in (ALP), with an average decrease of 250 versus 10 for responders versus nonresponders. Pre-FMT alpha diversity was significantly less than that of controls; at one week post-FMT, microbiome diversity increased in all PSC patients, and it remained elevated in most patients. Variable taxonomic distributions were seen at the class level pre-FMT, while these distributions appeared more uniform post-FMT. Pre-FMT samples were enriched in Enterobacteriales and Fusobacterium compared with controls; in all post-FMT samples, Fusobacterium remained elevated, while Enterobacteriales exhibited a nonsignificant decrease.

"To our knowledge, this is the first study to demonstrate that FMT from a rationally selected donor is safe, increases microbial diversity, and may improve ALP among PSC patients," the authors write.

Several authors disclosed financial ties to pharmaceutical companies.


Explore further

Donor fecal microbiota transplant effective for C. difficile infection

More information: Abstract
More Information

Copyright © 2017 HealthDay. All rights reserved.

Citation: ACG: fecal transplant safe in primary sclerosing cholangitis (2017, October 16) retrieved 8 December 2019 from https://medicalxpress.com/news/2017-10-acg-fecal-transplant-safe-primary.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
56 shares

Feedback to editors

User comments